Keebeck Alpha, LP Tandem Diabetes Care Inc Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$53.22 - $123.09 $133,954 - $309,817	-2,517 Closed	0 $0
Q1 2022 Feb 01, 2023	BUY	$101.89 - $150.09 $256,457 - $377,776	2,517 New	2,517 $293,000
Q1 2022 May 10, 2022	BUY	$101.89 - $150.09 $67,247 - $99,059	660 Added 35.54%	2,517 $293,000
Q4 2021 Feb 09, 2022	SELL	$118.18 - $153.21 $80,362 - $104,182	-680 Reduced 26.8%	1,857 $280,000
Q3 2021 Nov 09, 2021	BUY	$93.51 - $129.4 $237,234 - $328,287	2,537 New	2,537 $303,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.